Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in pre-clinical models of aggressive lymphomas - refine.bio

GSE76757

Homo sapiens

6 Downloadable Samples

Illumina HumanHT-12 V4.0 expression beadchip

Submitter Supplied Information

Description

assess the efficacy of Pimasertib to characterize its mechanism of action

PubMed ID

Publication Title

Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas.

Total Samples

6

Submitter’s Institution

Authors

Gaudio E, Tarantelli C, Kwee I, Barassi C, Bernasconi E, Rinaldi A, Ponzoni M, Cascione L, Targa A, Stathis A, Goodstal S, Zucca E, Bertoni F

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

No rows found

Loading...